Abstract
The epidermal growth factor receptor (EGFR) and its ligands are involved in tumor growth, metastasis, angiogenesis, and resistance to chemotherapy. The findings reported here demonstrate that SN38 (the active metabolite of CPT-11) induces the tyrosine phosphorylation of EGFR within 5 min, followed by the induction of transcripts and/or proteins of the heparin-binding EGF-like growth factor, amphiregulin, transforming growth factor-α, and interlukin-8 (IL-8) in AGS gastric cancer cells. SN38 also activates nuclear factor-κB and activator protein-1, both of which are critical for the transcription of the IL-8 gene. However, the blocking of EGFR activation by gefitinib (“Iressa”, ZD1839), an EGFR-TKI (tyrosine kinase inhibitor), abrogates all the above reactions. The SN38-triggered mechanisms include the generation of reactive oxygen species (ROS) and the activation of protein kinase C (PKC), followed by metalloproteinase activation and the sequential ectodomain shedding of EGFR ligands. These findings suggest that EGF signaling is enhanced by CPT-11 and point to the potential benefit of the use of a combination of CPT-11 with gefitinib in the treatment of certain gastric cancers.
Similar content being viewed by others
Abbreviations
- AP-1:
-
Activator protein-1
- AR:
-
Amphiregulin
- CPT:
-
Camptothecin
- EGF:
-
Epidermal growth factor
- EGFR:
-
EGF receptor
- ELISA:
-
Enzyme-linked immunosorbent assay
- EMSA:
-
Electrophoretic mobility shift assay
- GAPDH:
-
Glyceraldehyde 3-phosphate dehydrogenase
- HB-EGF:
-
Heparin-binding EGF-like growth factor
- IL-8:
-
Interleukin-8
- NAC:
-
N-Acetylcysteine
- NF-κB:
-
Nuclear factor-kappaB
- ROS:
-
Reactive oxygen species
- TGF:
-
Transforming growth factor
References
Pommier Y, Pourquier P, Fan Y, Strumberg D (1998) Mechanism of action of eukaryotic DNA topoisomerase I and drugs targeted to the enzyme. Biochim Biophys Acta 1400:83–105
Kunimoto T, Nitta K, Tanaka T, Uehara N, Baba H, Takeuchi M, Yokokura T, Sawada S, Miyasaka T, Mutai M (1987) Antitumor activity of 7-ethyl-10-[4-(1-piperidino)-1-piperidino] carbonyloxy-camptothecin, a novel water-soluble derivative of camptothecin, against murine tumors. Cancer Res 47:5944–5947
Bleiberg H (1999) CPT-11 in gastrointestinal cancer. Eur J Cancer 35:371–379
Ajani JA, Baker J, Pisters PW, Ho L, Mansfield PF, Feig BW, Charnsangavej C (2001) CPT-11 plus cisplatin in patients with advanced, untreated gastric or gastroesophagus junction carcinoma. Cancer 94:641–646
Motwani M, Sirotnak FM, She Y, Commes T, Schwartz K (2002) Drg1, a novel target for modulating sensitivity to CPT-11 in colon cancer cells. Cancer Res 62:3950–3955
Hiraoka W, Vazquez N, Nieves-Neira W, Chanock SJ, Pommier Y (1998) Role of oxygen radicals generated by NADPH oxidase in apoptosis induced in human leukemia cells. J Clin Invest 102:1961–1968
Miyazaki Y, Hiraoka S, Tsutsui S, Kitamura S, Shinomura Y, Matsuzawa Y (2001) Epidermal growth factor receptor mediates stress-induced expression of its ligands in rat gastric epithelial cells. Gastroenterology 120:108–116
Huang RP, Peng A, Golard A, Hossain MZ, Huang R, Liu YG, Boynton AL (2001) Hydrogen peroxide promotes transformation of rat liver non-neoplastic epithelial cells through activation of epidermal growth factor receptor. Mol Carcinog 30:209–217
Borrell-Pages M, Rojo F, Albanell J, Baselga J, Arribas J (2003) TACE is required for activation of the EGFR by TGF-α in tumors. EMBO J 22:1114–1124
Hirata A, Ogawa S, Kometani T, Kuwano T, Naito S, Kuwano M, Ono M (2002) ZD1839 (Iressa) induces antiangiogenic effects through inhibition of epidermal growth factor receptor tyrosine kinase. Cancer Res 62:2554–2560
Ciadiello F, Tortora G (2001) A novel approach in the treatment of cancer: targeting the epidermal growth factor receptor. Clin Cancer Res 7:2958–2970
Mendelsohn J, Baselga J (2000) The EGF receptor family as targets for cancer therapy. Oncogene 19:6550–6565
Ciardiello F, Caputo R, Bianco R, Damiano V, Fontanini G, Cuccato S, Placido S, De Bianco AR, Tortora G (2001) Inhibition of growth factor production and angiogenesis in human cancer cells by ZD1839 (Iressa), a selective epidermal growth factor receptor tyrosine kinase inhibitor. Clin Cancer Res 7:1459–1465
Huang SM, Li J, Armstrong EA, Harari PM (2002) Modulation of radiation response and tumor-induced angiogenesis after epidermal growth factor receptor inhibition by ZD1839 (Iressa). Cancer Res 62:4300–4306
Raben D, Helfrich BA, Chan D, Johnson G, Bunn PA Jr (2002) ZD1839, a selective epidermal growth factor receptor tyrosine kinase inhibitor, alone and in combination with radiation and chemotherapy as a new therapeutic strategy in non-small cell lung cancer. Semin Oncol 29:37–46
Douglass EC (2003) Development of ZD1839 in colorectal cancer. Semin Oncol 30:17–22
Hiraoka S, Miyazaki Y, Kitamura S, Toyota M, Kiyohara T, Shinomura Y, Mukaida N, Matsuzawa Y (2001) Gastrin induces CXC chemokine expression in gastric epithelial cells through activation of NF-κB. Am J Physiol Gastrointest Liver Physiol 281:G735–G742
Digman JD, Lebovit RM, Roeder RG (1983) Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 11:1475–1489
Noguchi H, Sakamoto C, Wada K, Akamatsu T, Uchida T, Tatsuguchi A, Matsui H, Fukui H, Fujimori T, Kasuga M (1999) Expression of Heregulin α, erbB2, and erbB3 and their influences on proliferation of gastric epithelial cells. Gastroenterology 117:1119–1127
Normanno N, Bianco C, De Luca A, Maiello MR, Salomon DS (2003) Target-based agents against ErbB receptors and their ligands: a novel approach to cancer treatment. Endocr Relat Cancer 10:1–21
Simizu S, Takada M, Umezawa K, Imoto M (1998) Requirement of caspase-3(-like) protease-mediated hydrogen peroxide production for apoptosis induced by various anticancer drugs. J Biol Chem 273:26900–26907
Lemjabbar H, Li D, Gallup M, Sidhu S, Drori E, Basbaum C (2003) Tobacco smoke-induced lung cell proliferation mediated by tumor necrosis factor alpha-converting enzyme and amphiregulin. J Biol Chem 278:26202–26207
Takenobu H, Yamazaki A, Hirata M, Umata T, Mekada E (2003) The stress- and inflammatory cytokine-induced ectodomain shedding of heparin-binding epidermal growth factor-like growth factor is mediated by p38 MAPK, distinct from the 12-O-tetradecanoylphorbol-13-acetate- and lysophosphatidic acid-induced signaling cascades. J Biol Chem 278:17255–17262
Prenzel N, Zwick E, Daub H, Leserer M, Abraham R, Wallasch C, Ullrich A (1999) EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature 402:884–888
Barnard JA, Graves-Deal R, Pittelkow MR, Dubois RN, Cook P, Ramsey GW, Bishop PR, Damstrup L, Coffey RJ (1994) Auto- and cross-induction within the mammalian epidermal growth factor-related polypeptide family. J Biol Chem 269:22817–22822
Huang S, Mills L, Mian B, Tellez C, McCarty M, Yang X-D, Gudas JM, Bar-Eli M (2002) Fully humanized neutralizing antibodies to interleukin-8 (ABX-IL-8) inhibit angiogenesis, tumor growth, and metastasis of human melanoma. Am J Pathol 161:125–134
Mukaida N, Mahe Y, Matsushima K (1990) Cooperative interaction of nuclear factor-κB- and cis-regulatory enhancer binding protein-like factor binding elements in activating the interleukin-8 gene by pro-inflammatory cytokines. J Biol Chem 265:21128–21133
Naef M, Yokoyama M, Friess H, Buchler MW, Korc M (1996) Co-expression of heparin-binding EGF-like growth factor and related peptides in human gastric carcinoma. Int J Cancer 66:315–321
Ravid T, Sweeney C, Gee P, Carraway KL III, Goldkorn T (2002) Epidermal growth factor receptor activation under oxidative stress fails to promote c-Cbl mediated down-regulation. J Biol Chem 277:31214–31219
Konishi H, Tanaka M, Takemura Y, Matsuzaki H, Ono Y, Kikkawa U, Nishizuka Y (1997) Activation of protein kinase C by tyrosine phosphorylation in response to H2O2. Proc Natl Acad Sci U S A 94:11233–11237
Sun X, Wu F, Datta R, Kharbanda S, Kufe D (2000) Interaction between protein kinase C delta and the c-Abl tyrosine kinase in the cellular response to oxidative stress. J Biol Chem 275:7470–7473
Majumder PK, Mishra NC, Sun X, Bharti A, Kharbanda S, Saxena S, Kufe D (2001) Targeting of protein kinase C delta to mitochondria in the oxidative stress response. Cell Growth Differ 12:465–470
Cesaro P, Raiteri E, Demoz M, Castino R, Baccino FM, Bonelli G, Isidoro C (2001) Expression of protein kinase C beta1 confers resistance to TNF alpha- and paclitaxel-induced apoptosis in HT-29 colon carcinoma cells. Int J Cancer 93:179–184
Han Y, Han ZY, Zhou XM, Shi R, Zheng Y, Shi YQ, Miao JY, Pan BR, Fan DM (2002) Expression and function of classical protein kinase C isoenzymes in gastric cancer cell line and its drug-resistant sublines. World J Gastroenterol 8:441–445
Kitadai Y, Haruma K, Mukaida N, Ohmoto Y, Matsutani N, Yasui W, Yamamoto S, Sumii K, Kajiyama G, Fidler IJ, Tahara E (2000) Regulation of disease-progression genes in human gastric carcinoma cells by Interleukin 8. Clin Cancer Res 6:2735–2740
Bottero V, Busuttil V, Loubat A, Magnè N, Fischel J-L, Milano G, Peyron J-F (2001) Activation of nuclear factor κB through the IKK complex by the topoisomerase poisons SN38 and doxorubicin: a brake to apoptosis in HeLa human carcinoma cells. Cancer Res 61:7785–7791
Acknowledgements
This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan.
Author information
Authors and Affiliations
Corresponding author
Additional information
“Iressa” is a trademark of the AstraZeneca group of companies.
Rights and permissions
About this article
Cite this article
Kishida, O., Miyazaki, Y., Murayama, Y. et al. Gefitinib (“Iressa”, ZD1839) inhibits SN38-triggered EGF signals and IL-8 production in gastric cancer cells. Cancer Chemother Pharmacol 55, 393–403 (2005). https://doi.org/10.1007/s00280-004-0904-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00280-004-0904-0